Asset Details
Do you wish to reserve the book?
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
Do you wish to request the book?
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
2016
Overview
Background:
The purpose of this study was to develop a nomogram to predict ‘poor prognosis recurrence’ (PPR) in women treated for endometrial cancer (EC).
Methods:
The data of 861 women who received primary surgical treatment between January 2001 and December 2013 were abstracted from a prospective multicenter database. Data were randomly split into two sets: training and validation with a predefined 2/3 ratio. A Cox proportional hazards multivariate model of selected prognostic features was performed in the training cohort (
n
=574) to develop a nomogram predicting PPRs. The nomogram was validated in the validation cohort of 287 patients.
Results:
In the training cohort, 82 (14.3%) developed subsequent PPR. Age, histologic type and grade, lymphovascular space invasion status, FIGO stage, and nodal staging (SLN±pelvic and/or para-aortic lymphadenectomy) were independently associated with subsequent PPR. The nomogram showed an area under the receiver operating characteristic curve (AUC) of 0.82 (95% confidence interval (CI), 0.73–0.89) in the training set. The validation set showed a good discrimination with an AUC of 0.75 (95% CI, 0.65–0.83).
Conclusions:
We have developed a robust tool that is able to predict subsequent PPRs in women with FIGO I–III EC.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Cancer Research UK
Subject
